Sign in

NCT03287544Completed

Efficacy of a Combined Linguistic/Communication Therapy in Acute Aphasia After Stroke

Effect of a Combined Language Therapy (Linguistic/Communication) on Aphasia After Stroke in Acute Phase: A Prospective, Controlled, Monocentric Pilot Study

Source: ClinicalTrials.gov · Last updated 3 Jan 2024

Brief summary (registry, in English)

Linguistic training is traditionally the gold standard for rehabilitation of aphasia after stroke and efficacy criteria count early stage, intensity as well as personalized treatment. To date, no clear evidence showed a specific effect of any therapy in the acute phase of aphasia after stroke. This study aims to compare the effect of a combined therapy (linguistic/communication) versus a linguistic therapy on communication performance in patients in the acute phase of aphasia after a first stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
19 (actual)
First submitted
21 Aug 2017
Start date
1 Mar 2018
Primary completion date
30 Jun 2022
Lead sponsor
University Hospital, Toulouse
Diseases
Stroke
NCT number
NCT03287544

What you commit to

  • Study type: Interventional
  • Participants enrolled: 19
  • From 1 Mar 2018 to the primary completion date, 30 Jun 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Alcohol or drug addiction

Other illness

  • Cognitive impairment before the onset (IQCode \> 3.4)
  • Untreated psychiatric disease,
  • Uncorrected sensory impairment

Other

  • Evolutive pathology
  • Adults protected by Law
  • Participation to another research

Who the study is looking for

  • First stroke
  • Inclusion at the acute phase (\< 7 days)
  • Patient registered at the social security system
  • French as usual language
  • Aphasia severity score measured by the Boston Diagnostic Aphasia Examination (BDAE) scale ≥ 1 and ≤ 4
  • Consent signed by the patient or if not, by the caregiver

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Pierre Paul Riquet
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.